* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected
to show a
rise in quarterly revenue when it reports results on March 1.
* The Solana Beach California-based company is expected to
report
a 15.7% increase in revenue to $4.3 million from $3.72 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Clearpoint Neuro
Inc is
for a loss of 19 cents per share. For the same quarter last
year, the company reported a loss of 9 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $32, about 73.4% above its last closing price
of $8.52.
This summary was machine generated February 25 at 23:26 GMT.
All figures in US dollars unless otherwise stated